Context Therapeutics (CNTX) EBITDA Margin (2021 - 2026)
Context Therapeutics (CNTX) reported EBITDA Margin of -2398.18% for Q3 2026, down 1126.08 percentage points from -1272.10% a year earlier but up 1175.30 percentage points from the prior quarter.
Context Therapeutics (CNTX) EBITDA Margin (2021 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Context Therapeutics' EBITDA Margin came in at -2358.20%, down 1533.27 percentage points year-over-year; for FY2025, it came in at -1174.66%, down 239.94 percentage points from FY2024.
- EBITDA Margin has a three-year change of +1634.19 percentage points (FY2022 to FY2025).
- By year, EBITDA Margin came in at -934.72% in FY2024 (+1218.30 pp), -2153.02% in FY2023 (+655.83 pp) and -2808.85% in FY2022.
- Five-year quarterly EBITDA Margin spans a low of -981556.83% in Q4 2021 and a high of -367.31% in Q2 2024.
- Year over year, EBITDA Margin has now declined in each of the last four quarters, with an average year-over-year change of -290.80 percentage points over the last eight quarters.
- The high point for year-over-year EBITDA Margin in five years was Q4 2022 (a gain of 980373.66 percentage points); the low point was Q2 2026 (a drop of 2494.19 percentage points).
- Per Business Quant data, the three quarters before Q3 2026 came in at -3573.48% (Q2 2026), -1795.50% (Q1 2026) and -2022.11% (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | PetVivo Holdings | 3,096.39 Bn | 3,096.39 Bn | 196,075.00 | -883.96% |
| 2 | Eli Lilly | 1,202.70 Bn | 1,176.32 Bn | 20.46 Bn | 36.69% |
| 3 | Johnson & Johnson | 649.77 Bn | 569.63 Bn | 17.30 Bn | 32.68% |
| 4 | AbbVie | 507.00 Bn | 475.00 Bn | 13.12 Bn | 46.88% |
| 5 | Merck | 329.70 Bn | 292.64 Bn | 13.19 Bn | 40.60% |
| 6 | Novartis Ag | 291.91 Bn | 265.14 Bn | - | - |
| 7 | Amgen | 236.26 Bn | 187.91 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 207.15 Bn | 182.26 Bn | 6.73 Bn | 50.63% |
| 9 | Gsk | 193.54 Bn | 176.38 Bn | - | - |
| 10 | Context Therapeutics | 15.24 Mn | -182.70 Mn | - | -2,398.18% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -2,398.18% |
| Jun 30, 2026 | -3,573.48% |
| Mar 31, 2026 | -1,795.50% |
| Dec 31, 2025 | -2,022.11% |
| Sep 30, 2025 | -1,272.10% |
| Jun 30, 2025 | -1,079.29% |
| Mar 31, 2025 | -576.42% |
| Dec 31, 2024 | -446.82% |
| Sep 30, 2024 | -1,503.48% |
| Jun 30, 2024 | -367.31% |
| Mar 31, 2024 | -2,507.98% |
| Dec 31, 2023 | -3,084.13% |
| Sep 30, 2023 | -2,126.91% |
| Jun 30, 2023 | -1,803.49% |
| Mar 31, 2023 | -1,874.14% |
| Dec 31, 2022 | -1,183.16% |
| Sep 30, 2022 | -2,104.03% |
| Jun 30, 2022 | -18,806.02% |
| Mar 31, 2022 | -58,713.54% |
| Dec 31, 2021 | -981,556.83% |
Context Therapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CNTX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "CNTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CNTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();